遺伝子組み換えマウス上皮成長因子試薬市場レポート：動向、予測、競合分析 (2031年まで)

世界の遺伝子組み換えマウス上皮成長因子試薬市場の将来性は有望で、生物学研究所と大学市場における機会が期待されています。遺伝子組み換えマウス上皮成長因子試薬の世界市場は、2025年から2031年にかけてCAGR 10.5％で成長すると予想されます。この市場の主な促進要因は、創傷治癒に対する需要の増加、化粧品製剤への使用の増加、組織再生の研究の増加です。

• Lucintelの予測では、種類別では純度95%以上が予測期間中に高い成長を遂げる見込みです。
• 用途別では、生物学研究室がより高い成長を遂げると予想されます。
• 地域別では、北米が予測期間中に最も高い成長が見込まれます。

遺伝子組み換えマウス上皮成長因子試薬市場の新たな動向

遺伝子組み換えマウス上皮成長因子試薬市場は、生物医学研究のニーズの進化、実験の再現性向上の推進、タンパク質生産の進歩によって形成された、いくつかの主要な新興動向を目の当たりにしています。これらの動向は、多様な科学的試みをサポートするために、より高品質で、より専門的で、倫理的に調達された試薬へのシフトを強調しています。

• 動物由来でない試薬：動物由来でないシステムで生産された組換えマウスEGF試薬に対する需要が強く、増加しています。この動向は、不定性因子のリスクを最小化し、高感度研究や潜在的な臨床応用のための一貫した定義された細胞培養条件を確保する必要性によって推進されています。
• 純度と生理活性の向上：メーカー各社は、著しく高い純度レベルと証明された生物学的活性を有する組換えマウスEGFの生産に注力しています。これにより、細胞培養実験、シグナル伝達経路研究、薬剤スクリーニングアッセイにおいて、科学的完全性にとって極めて重要な、信頼性と再現性の高い結果が保証されます。
• オルガノイドおよび3次元細胞培養への応用：オルガノイドや3次元細胞培養の分野は急成長しており、組換えマウスEGFの需要を高めています。EGFは、様々なタイプのオルガノイドを維持・拡大するための多くの化学的に定義された培地における重要な成分であり、疾患研究のための、より生理学的に適切なin vitroモデルを促進します。
• 費用効果が高く、スケーラブルな生産：研究が世界的に拡大するにつれて、組換えマウスEGF試薬のコスト効率が高く、スケーラブルな生産方法に対するニーズが高まっています。これには、高品質な試薬をより多くの研究者が利用できるようにするための発現系や精製プロセスの最適化も含まれます。
• 特殊な変異体の開発：研究開発者たちは、リコンビナントマウスEGFの特殊な変異体や改良型を探索・開発しています。これらの変異体は、安定性の向上、レセプター結合特異性の変更、活性の延長などを提供し、マウスモデルに対する特定の研究ニーズや治療開発に対応しています。

このような動向は総体的に、組換えマウスEGF試薬市場を、より洗練された、倫理的意識の高い、高性能な業界へと再構築しつつあります。明確に定義された、高品質かつ用途に特化した試薬に重点を置くことは、生物医学研究を前進させ、より複雑なin vitroモデルを可能にし、将来の治療戦略の開発をサポートするために極めて重要です。

遺伝子遺伝子組み換えマウス上皮成長因子試薬市場における最近の動向

遺伝子組み換えマウス上皮成長因子試薬市場は、主に多くの生物学的研究用途におけるその基礎的役割と実験モデルの高度化によって、継続的な開拓が行われています。最近の主な動向は、生産手法、品質管理、様々な科学分野にわたる有用性の拡大における著しい進歩に焦点を当てています。

• 改良された発現システム：製造業者は組換えマウスEGF生産に高度な微生物及び哺乳動物発現系を利用するようになってきており、収率の向上、フォールディングの改善、生物学的活性の強化につながり、それによって生産の効率と費用対効果を高めています。
• 精製技術の向上：より洗練されたクロマトグラフィーと濾過法の採用により、極めて純度の高い組換えマウスEGF試薬が生み出され、汚染物質を最小限に抑え、高感度な細胞培養と生化学的アッセイにおいて一貫した信頼性の高い性能を保証しています。
• 動物不使用製品の導入：動物由来成分を一切含まない組換えマウスEGF試薬の広範な入手可能性は、重要な開発です。これは不定夾雑物に関する懸念に対処し、より明確で一貫性のある細胞培養用試薬を提供します。
• オルガノイドおよび3D培養系における使用の拡大：組換えマウスEGFは、急速に成長しつつあるオルガノイドや3D細胞培養の分野において、欠くことのできない成分となりつつあります。これらの複雑なモデルにおいて細胞増殖と生存を促進する上で重要な役割を果たすことから、需要が高まり、特殊な製剤が開発されるようになりました。
• 市販の細胞培養培地への統合：多くの市販の化学的に定義された細胞培養培地は、現在、組換えマウスEGFを標準成分として含んでいます。この統合は研究者のワークフローを合理化し、様々なタイプの細胞の最適な増殖と分化を保証し、実験の再現性を高めます。

これらの開発は、研究者により高品質で、より信頼性が高く、より安全なツールを提供することで、組換えマウスEGF試薬市場に総合的な影響を与えています。生産性、純度の向上、最新の細胞培養技術への統合に焦点を当てることは、科学的発見を加速し、急速に進化する生物医学研究の状況をサポートするために極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 世界の遺伝子組み換えマウス上皮成長因子試薬市場：種類別

• 概要
• 魅力分析：種類別
• 純度95%以上：動向と予測（2019～2031年）
• 純度95%以下：動向と予測（2019～2031年）

第5章 用途別遺伝子組み換えマウス上皮成長因子試薬市場

• 概要
• 用途別魅力分析
• 生物学研究所：動向と予測（2019～2031年）
• 大学：動向と予測（2019～2031年）
• その他：動向と予測（2019～2031年）

第6章 地域分析

• 概要
• 世界の遺伝子組み換えマウス上皮成長因子試薬市場：地域別

第7章 北米の遺伝子組み換えマウス上皮成長因子試薬市場

• 概要
• 北米の遺伝子組み換えマウス上皮成長因子試薬市場：種類別
• 北米の遺伝子組み換えマウス上皮成長因子試薬市場：用途別
• 米国の遺伝子組み換えマウス上皮成長因子試薬市場
• メキシコの遺伝子組み換えマウス上皮成長因子試薬市場
• カナダの遺伝子組み換えマウス上皮成長因子試薬市場

第8章 欧州の遺伝子組み換えマウス上皮成長因子試薬市場

• 概要
• 欧州の遺伝子組み換えマウス上皮成長因子試薬市場：種類別
• 欧州の遺伝子組み換えマウス上皮成長因子試薬市場：用途別
• ドイツの遺伝子組み換えマウス上皮成長因子試薬市場
• フランスの遺伝子組み換えマウス上皮成長因子試薬市場
• スペインの遺伝子組み換えマウス上皮成長因子試薬市場
• イタリアの遺伝子組み換えマウス上皮成長因子試薬市場
• 英国の遺伝子組み換えマウス上皮成長因子試薬市場

第9章 アジア太平洋の遺伝子組み換えマウス上皮成長因子試薬市場

• 概要
• アジア太平洋の遺伝子組み換えマウス上皮成長因子試薬市場：種類別
• アジア太平洋の遺伝子組み換えマウス上皮成長因子試薬市場：用途別
• 日本の遺伝子組み換えマウス上皮成長因子試薬市場
• インドの遺伝子組み換えマウス上皮成長因子試薬市場
• 中国の遺伝子組み換えマウス上皮成長因子試薬市場
• 韓国の遺伝子組み換えマウス上皮成長因子試薬市場
• インドネシアの遺伝子組み換えマウス上皮成長因子試薬市場

第10章 その他の地域 (ROW) の遺伝子組み換えマウス上皮成長因子試薬市場

• 概要
• その他の地域 (ROW) の遺伝子組み換えマウス上皮成長因子試薬市場：種類別
• その他の地域 (ROW) の遺伝子組み換えマウス上皮成長因子試薬市場：用途別
• 中東の遺伝子組み換えマウス上皮成長因子試薬市場
• 南米の遺伝子組み換えマウス上皮成長因子試薬市場
• アフリカの遺伝子組み換えマウス上皮成長因子試薬市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • 成長機会：種類別
  • 成長機会：用途別
• 世界の遺伝子組み換えマウス上皮成長因子試薬市場の新たな動向
• 戦略分析
  • 新製品開発
  • 認証・ライセンシング
  • 企業合併・買収 (M&A) 、契約、提携、合弁事業

第13章 バリューチェーン上の主要企業のプロファイル

• Competitive Analysis
• Novartis
• Amgen
• Betta Pharmaceuticals
• Thermo Fisher Scientific
• Eli Lilly and Company
• Bio-Techne
• Merck
• Yeasen
• Sino Biological
• Miltenyi Biotec

第14章 付録

• 図の一覧
• 表の一覧
• 分析手法
• 免責事項
• 著作権
• 略語と技術単位
• Lucintelについて
• お問い合わせ

List of Figures

• Figure 1.1: Trends and Forecast for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 2.1: Usage of Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 2.2: Classification of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 2.3: Supply Chain of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 2.4: Driver and Challenges of the Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type
• Figure 4.3: Forecast for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type
• Figure 4.4: Trends and Forecast for Purity>95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 4.5: Trends and Forecast for Purity<=95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 5.1: Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application
• Figure 5.3: Forecast for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application
• Figure 5.4: Trends and Forecast for Biological Laboratories in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 5.5: Trends and Forecast for University in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 5.6: Trends and Forecast for Others in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 6.1: Trends of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 7.2: North American Recombinant Mouse Epidermal Growth Factor Reagent Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2025-2031)
• Figure 7.5: North American Recombinant Mouse Epidermal Growth Factor Reagent Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 8.2: European Recombinant Mouse Epidermal Growth Factor Reagent Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2025-2031)
• Figure 8.5: European Recombinant Mouse Epidermal Growth Factor Reagent Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 9.2: APAC Recombinant Mouse Epidermal Growth Factor Reagent Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Recombinant Mouse Epidermal Growth Factor Reagent Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Figure 10.2: ROW Recombinant Mouse Epidermal Growth Factor Reagent Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Recombinant Mouse Epidermal Growth Factor Reagent Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Recombinant Mouse Epidermal Growth Factor Reagent Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market
• Figure 11.2: Market Share (%) of Top Players in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2024)
• Figure 12.1: Growth Opportunities for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• Figure 12.2: Growth Opportunities for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• Figure 12.3: Growth Opportunities for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Region
• Figure 12.4: Emerging Trends in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Recombinant Mouse Epidermal Growth Factor Reagent Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Recombinant Mouse Epidermal Growth Factor Reagent Market by Region
• Table 1.3: Global Recombinant Mouse Epidermal Growth Factor Reagent Market Parameters and Attributes
• Table 3.1: Trends of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 3.2: Forecast for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 4.4: Trends of Purity>95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 4.5: Forecast for Purity>95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 4.6: Trends of Purity<=95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 4.7: Forecast for Purity<=95% in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 5.4: Trends of Biological Laboratories in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 5.5: Forecast for Biological Laboratories in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 5.6: Trends of University in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 5.7: Forecast for University in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 5.8: Trends of Others in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 5.9: Forecast for Others in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 7.1: Trends of the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 7.2: Forecast for the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 8.1: Trends of the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 8.2: Forecast for the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 9.1: Trends of the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 9.2: Forecast for the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 10.1: Trends of the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 10.2: Forecast for the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Recombinant Mouse Epidermal Growth Factor Reagent Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Recombinant Mouse Epidermal Growth Factor Reagent Market (2019-2031)
• Table 11.1: Product Mapping of Recombinant Mouse Epidermal Growth Factor Reagent Suppliers Based on Segments
• Table 11.2: Operational Integration of Recombinant Mouse Epidermal Growth Factor Reagent Manufacturers
• Table 11.3: Rankings of Suppliers Based on Recombinant Mouse Epidermal Growth Factor Reagent Revenue
• Table 12.1: New Product Launches by Major Recombinant Mouse Epidermal Growth Factor Reagent Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market

The future of the global recombinant mouse epidermal growth factor reagent market looks promising with opportunities in the biological laboratory and university markets. The global recombinant mouse epidermal growth factor reagent market is expected to grow with a CAGR of 10.5% from 2025 to 2031. The major drivers for this market are the increasing demand for wound healing, the rising use in cosmetic formulations, and the growing research in tissue regeneration.

• Lucintel forecasts that, within the type category, purity >95% is expected to witness higher growth over the forecast period.
• Within the application category, biological laboratory is expected to witness higher growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Recombinant Mouse Epidermal Growth Factor Reagent Market

The recombinant mouse epidermal growth factor reagent market is witnessing several key emerging trends, shaped by the evolving needs of biomedical research, the push for greater experimental reproducibility, and advancements in protein production. These trends highlight a shift towards higher quality, more specialized, and ethically sourced reagents to support diverse scientific endeavors.

• Animal-Origin-Free Reagents: There is a strong and increasing demand for recombinant mouse EGF reagents produced in animal-origin-free systems. This trend is driven by the need to minimize the risk of adventitious agents and to ensure consistent, defined cell culture conditions for sensitive research and potential clinical applications.
• Enhanced Purity and Bioactivity: Manufacturers are focusing on producing recombinant mouse EGF with significantly higher purity levels and proven biological activity. This ensures reliable and reproducible results in cell culture experiments, signaling pathway studies, and drug screening assays, which are critical for scientific integrity.
• Application in Organoid and 3D Cell Culture: The burgeoning fields of organoid and 3D cell culture are driving increased demand for recombinant mouse EGF. It is a vital component in many chemically defined media for maintaining and expanding various organoid types, facilitating more physiologically relevant in vitro models for disease research.
• Cost-Effective and Scalable Production: As research expands globally, there is a growing need for cost-effective and scalable production methods for recombinant mouse EGF reagents. This includes optimizing expression systems and purification processes to make high-quality reagents more accessible to a wider range of researchers.
• Development of Specialized Variants: Researchers are exploring and developing specialized variants or modified forms of recombinant mouse EGF. These variants may offer enhanced stability, altered receptor binding specificities, or prolonged activity, catering to specific research needs or therapeutic development for murine models.

These trends are collectively reshaping the recombinant mouse EGF reagent market towards a more sophisticated, ethically conscious, and high-performance industry. The emphasis on defined, high-quality, and application-specific reagents is crucial for advancing biomedical research, enabling more complex in vitro models, and supporting the development of future therapeutic strategies.

Recent Developments in the Recombinant Mouse Epidermal Growth Factor Reagent Market

The recombinant mouse epidermal growth factor reagent market is undergoing continuous development, primarily driven by its foundational role in numerous biological research applications and the increasing sophistication of experimental models. Recent key developments highlight significant advancements in production methodologies, quality control, and the expansion of its utility across various scientific disciplines.

• Improved Expression Systems: Manufacturers are increasingly utilizing advanced microbial and mammalian expression systems for recombinant mouse EGF production, leading to higher yields, improved folding, and enhanced biological activity, thereby increasing the efficiency and cost-effectiveness of production.
• Enhanced Purification Techniques: The adoption of more sophisticated chromatography and filtration methods has resulted in recombinant mouse EGF reagents with exceptionally high purity, minimizing contaminants and ensuring consistent, reliable performance in sensitive cell culture and biochemical assays.
• Introduction of Animal-Free Products: A significant development is the widespread availability of recombinant mouse EGF reagents produced without any animal-derived components. This addresses concerns about adventitious agents and provides a more defined and consistent reagent for cell culture.
• Expanding Use in Organoid and 3D Culture Systems: Recombinant mouse EGF is becoming an indispensable component in the rapidly growing field of organoid and 3D cell culture. Its critical role in promoting cell proliferation and survival in these complex models has driven increased demand and specialized formulations.
• Integration into Commercial Cell Culture Media: Many commercially available, chemically defined cell culture media now include recombinant mouse EGF as a standard component. This integration streamlines workflows for researchers, ensuring optimal growth and differentiation of various cell types, enhancing experimental reproducibility.

These developments are collectively impacting the recombinant mouse EGF reagent market by providing researchers with higher quality, more reliable, and safer tools. The focus on improved production, purity, and integration into modern cell culture techniques is crucial for accelerating scientific discovery and supporting the rapidly evolving landscape of biomedical research.

Strategic Growth Opportunities in the Recombinant Mouse Epidermal Growth Factor Reagent Market

The recombinant mouse epidermal growth factor reagent market offers several strategic growth opportunities by targeting specific applications that leverage its potent cell proliferation and differentiation capabilities. By focusing on areas with high research intensity and evolving experimental needs, manufacturers can expand their market presence and drive innovation, contributing to advancements in various life science disciplines.

• Stem Cell Research and Culture: The rapidly expanding field of stem cell research, including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), provides a significant opportunity for recombinant mouse EGF as a critical component in chemically defined media for maintaining pluripotency and promoting differentiation.
• Organoid and 3D Cell Culture Models: The increasing adoption of organoid and 3D cell culture systems for disease modeling, drug screening, and regenerative medicine offers a robust growth area. Recombinant mouse EGF is essential for supporting the growth and integrity of various tissue-specific organoids.
• Wound Healing and Tissue Repair Studies: Research into wound healing mechanisms and tissue regeneration heavily utilizes recombinant mouse EGF due to its known role in stimulating epidermal cell proliferation and migration. This application provides a steady demand for high-quality reagents in dermatology and regenerative medicine research.
• Cancer Research and Drug Discovery: The role of EGF and its receptor (EGFR) in cancer progression and metastasis creates a strong demand for recombinant mouse EGF as a reagent in oncology research, including in vitro assays for anti-cancer drug screening and understanding signaling pathways.
• Development of In Vitro Fertilization (IVF) Media: Recombinant mouse EGF is increasingly used in specialized media for in vitro fertilization (IVF) research and procedures, particularly in murine models. Its role in supporting oocyte maturation and embryonic development offers a niche but important growth opportunity.

These strategic growth opportunities are reshaping the recombinant mouse EGF reagent market by directing investment and innovation towards high-impact research areas. By focusing on critical applications, manufacturers can develop tailored solutions, support cutting-edge scientific inquiries, and solidify the market's role as a fundamental supplier for advancing biological and medical understanding.

Recombinant Mouse Epidermal Growth Factor Reagent Market Driver and Challenges

The recombinant mouse epidermal growth factor reagent market is influenced by a dynamic interplay of factors. Major drivers include the expanding scope of cell culture research, the growth of organoid and 3D culture technologies, and increasing investment in life science research. However, significant challenges such as high production costs, maintaining lot-to-lot consistency, and competition from alternative growth factors pose considerable hurdles for market stakeholders.

The factors responsible for driving the recombinant mouse epidermal growth factor reagent market include:

1. Expanding Cell Culture Research: The continuous growth in basic and applied cell culture research across various disciplines, including developmental biology, neurobiology, and immunology, directly drives the demand for recombinant mouse EGF as a crucial growth factor.

2. Growth of Organoid and 3D Culture Technologies: The rapid adoption of more complex and physiologically relevant organoid and 3D cell culture models in drug discovery and disease modeling necessitates the use of high-quality recombinant mouse EGF for maintaining cellular health and tissue architecture.

3. Increasing Investment in Life Science Research: Global increases in funding for biotechnology, pharmaceutical research, and academic life sciences fuel the demand for high-quality research reagents, including recombinant mouse EGF, to support a wide array of experimental designs.

4. Demand for Defined and Animal-Free Media: The industry's shift towards chemically defined and animal-origin-free cell culture media to reduce variability and ensure reproducibility is a significant driver for high-purity recombinant mouse EGF reagents.

5. Role in Pre-clinical Drug Discovery: Recombinant mouse EGF is an essential component in many in vitro and in vivo pre-clinical drug discovery assays, particularly those involving cell proliferation, differentiation, and receptor signaling, ensuring its continued relevance in pharmaceutical R&D.

Challenges in the recombinant mouse epidermal growth factor reagent market are:

1. High Production and Purification Costs: The complexity of expressing, purifying, and validating recombinant mouse EGF to achieve high purity and biological activity results in relatively high manufacturing costs, which can impact the overall price of the reagent for researchers.

2. Maintaining Lot-to-Lot Consistency: Ensuring consistent biological activity and purity across different production batches of recombinant mouse EGF can be challenging. Batch variability can affect experimental reproducibility, posing a significant concern for researchers.

3. Competition from Alternative Growth Factors: While essential for specific applications, recombinant mouse EGF faces competition from other growth factors or synthetic alternatives that might offer similar proliferative effects or be preferred for certain cell types, potentially limiting its market share in some segments.

The market is significantly propelled by expanding cell culture research, the rise of 3D culture, and increased life science funding, underscoring its indispensable role. However, high production costs, the challenge of maintaining consistency, and competition from alternatives necessitate continuous innovation in manufacturing and quality control. Addressing these challenges is crucial for sustained growth and broader adoption of recombinant mouse EGF reagents in research.

List of Recombinant Mouse Epidermal Growth Factor Reagent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, recombinant mouse epidermal growth factor reagent companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the recombinant mouse epidermal growth factor reagent companies profiled in this report include:

• Novartis
• Amgen
• Betta Pharmaceuticals
• Thermo Fisher Scientific
• Eli Lilly and Company
• Bio-Techne
• Merck
• Yeasen
• Sino Biological
• Miltenyi Biotec

Recombinant Mouse Epidermal Growth Factor Reagent Market by Segment

The study includes a forecast for the global recombinant mouse epidermal growth factor reagent market by type, application, and region.

Recombinant Mouse Epidermal Growth Factor Reagent Market by Type [Value from 2019 to 2031]:

• Purity >95%
• Purity <=95%

Recombinant Mouse Epidermal Growth Factor Reagent Market by Application [Value from 2019 to 2031]:

• Biological Laboratories
• University
• Others

Recombinant Mouse Epidermal Growth Factor Reagent Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Recombinant Mouse Epidermal Growth Factor Reagent Market

The recombinant mouse epidermal growth factor reagent market is experiencing notable developments, driven by its indispensable role in cell culture, regenerative medicine research, and drug discovery. Recent advancements across the United States, China, Germany, India, and Japan reflect innovations in production technologies, enhanced purity standards, and the expanding application of mouse EGF in various biological studies.

• United States: The US market for recombinant mouse EGF reagents is robust, propelled by extensive biotechnology research and development. Recent developments include increased demand for high-purity, animal-origin-free reagents for sensitive cell culture applications, and ongoing investment in advanced expression systems to ensure consistent quality and scalability for research institutions.
• China: China's recombinant mouse EGF reagent market is growing significantly, supported by expanding life science research and a focus on domestic production. Recent developments include increased availability of locally produced recombinant mouse EGF, a focus on cost-effective manufacturing, and its widespread use in basic research, particularly in studies related to cell proliferation and differentiation.
• Germany: The German market emphasizes precision and reliability in recombinant mouse EGF reagents, largely driven by strong academic and industrial research sectors. Recent developments include the adoption of advanced purification techniques for superior quality reagents, and a focus on providing highly active and consistent batches essential for reproducible experimental outcomes in cell biology.
• India: India's recombinant mouse EGF reagent market is expanding, fueled by increasing investment in bioscience research and academic pursuits. Recent developments include the growing availability of various recombinant mouse EGF products from both international and domestic suppliers, and its increasing utility in cell culture media for academic and early-stage drug discovery research.
• Japan: Japan's market for recombinant mouse EGF reagents prioritizes high-quality, specialized products for cutting-edge research. Recent developments include the strong demand for animal-free recombinant mouse EGF for organoid and stem cell culture, and continuous efforts to develop highly bioactive and stable forms essential for sophisticated in vitro studies and tissue engineering.

Features of the Global Recombinant Mouse Epidermal Growth Factor Reagent Market

• Market Size Estimates: Recombinant mouse epidermal growth factor reagent market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Recombinant mouse epidermal growth factor reagent market size by type, application, and region in terms of value ($B).
• Regional Analysis: Recombinant mouse epidermal growth factor reagent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the recombinant mouse epidermal growth factor market.
• Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the recombinant mouse epidermal growth factor market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the recombinant mouse epidermal growth factor reagent market by type (purity >95% and purity <=95%), application (biological laboratories, university, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Purity>95%: Trends and Forecast (2019-2031)
• 4.4 Purity<=95%: Trends and Forecast (2019-2031)

5. Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Biological Laboratories: Trends and Forecast (2019-2031)
• 5.4 University: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Recombinant Mouse Epidermal Growth Factor Reagent Market by Region

7. North American Recombinant Mouse Epidermal Growth Factor Reagent Market

• 7.1 Overview
• 7.2 North American Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• 7.3 North American Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• 7.4 United States Recombinant Mouse Epidermal Growth Factor Reagent Market
• 7.5 Mexican Recombinant Mouse Epidermal Growth Factor Reagent Market
• 7.6 Canadian Recombinant Mouse Epidermal Growth Factor Reagent Market

8. European Recombinant Mouse Epidermal Growth Factor Reagent Market

• 8.1 Overview
• 8.2 European Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• 8.3 European Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• 8.4 German Recombinant Mouse Epidermal Growth Factor Reagent Market
• 8.5 French Recombinant Mouse Epidermal Growth Factor Reagent Market
• 8.6 Spanish Recombinant Mouse Epidermal Growth Factor Reagent Market
• 8.7 Italian Recombinant Mouse Epidermal Growth Factor Reagent Market
• 8.8 United Kingdom Recombinant Mouse Epidermal Growth Factor Reagent Market

9. APAC Recombinant Mouse Epidermal Growth Factor Reagent Market

• 9.1 Overview
• 9.2 APAC Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• 9.3 APAC Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• 9.4 Japanese Recombinant Mouse Epidermal Growth Factor Reagent Market
• 9.5 Indian Recombinant Mouse Epidermal Growth Factor Reagent Market
• 9.6 Chinese Recombinant Mouse Epidermal Growth Factor Reagent Market
• 9.7 South Korean Recombinant Mouse Epidermal Growth Factor Reagent Market
• 9.8 Indonesian Recombinant Mouse Epidermal Growth Factor Reagent Market

10. ROW Recombinant Mouse Epidermal Growth Factor Reagent Market

• 10.1 Overview
• 10.2 ROW Recombinant Mouse Epidermal Growth Factor Reagent Market by Type
• 10.3 ROW Recombinant Mouse Epidermal Growth Factor Reagent Market by Application
• 10.4 Middle Eastern Recombinant Mouse Epidermal Growth Factor Reagent Market
• 10.5 South American Recombinant Mouse Epidermal Growth Factor Reagent Market
• 10.6 African Recombinant Mouse Epidermal Growth Factor Reagent Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Recombinant Mouse Epidermal Growth Factor Reagent Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Novartis
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Amgen
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Betta Pharmaceuticals
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Thermo Fisher Scientific
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Eli Lilly and Company
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Bio-Techne
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Merck
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Yeasen
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Sino Biological
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Miltenyi Biotec
  • Company Overview
  • Recombinant Mouse Epidermal Growth Factor Reagent Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us